Hikma continued strategic progress and updated full-year guidance following Custopharm acquisition Non catigories Hikma continued strategic progress and updated full-year guidance following Custopharm acquisition AETOSWire sarjatha 29 April، 2022 London, England – Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group, today provides an update on...Read More